CD9+ and CD82+ extracellular vesicles in synovial fluid differentiate aseptic from septic endoprosthesis loosening

Abstract

Aim: Extracellular vesicles (EVs) hold great promise as emerging biomarkers for a variety of diseases. However, their clinical application is still hindered by complex and time-consuming isolation procedures. A clinically relevant scenario where improved biomarker-based diagnostics are urgently needed is prosthetic joint loosening, which may result from either aseptic inflammation or periprosthetic joint infection (PJI) - two conditions requiring fundamentally different therapeutic approaches. This study investigated whether imaging flow cytometry (IFCM) enables the discrimination between aseptic and septic loosening by profiling EVs directly in minimally processed synovial fluid.

Methods: We analyzed synovial fluid from 35 aseptic and 13 septic cases using IFCM to detect surface marker-defined EV subpopulations without prior isolation. Samples were classified based on clinical and microbiological findings. Marker abundance was quantified and analyzed using logistic regression.

Results: Septic loosening was associated with significantly increased levels of CD82⁺ EVs and decreased levels of CD9⁺ EVs. CD82⁺ EVs showed a sensitivity of 83.3% and specificity of 90.0%, while CD9⁺ EVs demonstrated 100% specificity but lower sensitivity (58.8%) for aseptic loosening. CD82⁺ EV abundance was identified as an independent predictor of septic loosening.

Conclusion: IFCM enables rapid and direct detection of diagnostically relevant EVs in native synovial fluid. CD9⁺ and CD82⁺ EVs serve as promising biomarkers for distinguishing aseptic from septic endoprosthesis loosening, offering a fast and robust diagnostic tool that may complement current clinical diagnostics and support timely treatment decisions.

Keywords

Extracellular vesicles / synovial fluid / imaging flow cytometry / biomarkers / endoprosthesis

References

[1] Harding C,Stahl P.Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes.J Cell Biol1983;97:329-39 PMCID:PMC2112509

[2] Johnstone RM,Hammond JR,Turbide C.Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes).J Biol Chem1987;262:9412-20

[3] Dragovic RA,Brooks AS.Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis.Nanomedicine2011;7:780-8 PMCID:PMC3280380

[4] Sokolova V,Hornung S.Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy.Colloids Surf B Biointerfaces2011;87:146-50

[5] Coumans FA,Böing AN.Reproducible extracellular vesicle size and concentration determination with tunable resistive pulse sensing.J Extracell Vesicles2014;3:25922 PMCID:PMC4263901

[6] Hood JL, Pan H, Lanza GM, Wickline SA; Consortium for Translational Research in Advanced Imaging and Nanomedicine (C-TRAIN). Paracrine induction of endothelium by tumor exosomes. Lab Invest. 2009;89:1317-28. PMCID:PMC3316485

[7] Droste M,Jeruschke S.Single extracellular vesicle analysis performed by imaging flow cytometry and nanoparticle tracking analysis evaluate the accuracy of urinary extracellular vesicle preparation techniques differently.Int J Mol Sci2021;22:12436 PMCID:PMC8620260

[8] Srinivasan S,Cheah PS.Small RNA sequencing across diverse biofluids identifies optimal methods for exRNA isolation.Cell2019;177:446-62.e16 PMCID:PMC6557167

[9] Breitwieser K,Tertel T.Detailed characterization of small extracellular vesicles from different cell types based on tetraspanin composition by ExoView R100 platform.Int J Mol Sci2022;23:8544 PMCID:PMC9369185

[10] Helmink BA,Gao J.B cells and tertiary lymphoid structures promote immunotherapy response.Nature2020;577:549-55 PMCID:PMC8762581

[11] Tian Y,Gong M.Protein profiling and sizing of extracellular vesicles from colorectal cancer patients via flow cytometry.ACS Nano2018;12:671-80

[12] Görgens A,Ferrer-Tur R.Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material.J Extracell Vesicles2019;8:1587567 PMCID:PMC6442110

[13] Ricklefs FL,Reimer R.Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours.J Extracell Vesicles2019;8:1588555 PMCID:PMC6442086

[14] Welsh JA,Bremer M.A compendium of single extracellular vesicle flow cytometry.J Extracell Vesicles2023;12:e12299 PMCID:PMC9911638

[15] Welsh JA,Arkesteijn GJA.MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments.J Extracell Vesicles2020;9:1713526 PMCID:PMC7034442

[16] Tertel T,Maire C.High-resolution imaging flow cytometry reveals impact of incubation temperature on labeling of extracellular vesicles with antibodies.Cytometry A2020;97:602-9

[17] Tertel T,Stambouli O,James PF.Imaging flow cytometry challenges the usefulness of classically used extracellular vesicle labeling dyes and qualifies the novel dye Exoria for the labeling of mesenchymal stromal cell-extracellular vesicle preparations.Cytotherapy2022;24:619-28

[18] Tertel T,Đokić J.Serum-derived extracellular vesicles: novel biomarkers reflecting the disease severity of COVID-19 patients.J Extracell Vesicles2022;11:e12257 PMCID:PMC9451525

[19] Gundtoft PH,Schønheyder HC,Kjærsgaard-Andersen P.The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study.Acta Orthop2015;86:326-34 PMCID:PMC4443464

[20] Busch A, Jäger M, Wegner A, Haversath M; VITAS group. Vitamin E-blended versus conventional polyethylene liners in prostheses : prospective, randomized trial with 3-year follow-up. Orthopade 2020;49:1077-85.

[21] Busch A, Jäger M, Klebingat S, et al; VITAS-Group. Vitamin E-blended highly cross-linked polyethylene liners in total hip arthroplasty: a randomized, multicenter trial using virtual CAD-based wear analysis at 5-year follow-up. Arch Orthop Trauma Surg. 2020;140:1859-66.

[22] Mbalaviele G,Schett G.Inflammatory osteolysis: a conspiracy against bone.J Clin Invest2017;127:2030-9 PMCID:PMC5451216

[23] Tetreault MW,Kayupov E,Della Valle CJ.Are patients being evaluated for periprosthetic joint infection prior to referral to a tertiary care center?.Arthroplast Today2018;4:216-20 PMCID:PMC5994562

[24] Parvizi J,Antoci V.Diagnosis of periprosthetic joint infection: the utility of a simple yet unappreciated enzyme.J Bone Joint Surg Am2011;93:2242-8

[25] Kildow BJ,Brown TS,Fehring TK.Long term results of two-stage revision for chronic periprosthetic hip infection: a multicenter study.J Clin Med2022;11:1657 PMCID:PMC8952569

[26] Bjerke-Kroll BT,McLawhorn AS,Jules-Elysée KM.Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile.J Arthroplasty2014;29:877-82

[27] Sigmund IK,Windhager R.Diagnosing periprosthetic joint infections: a comparison of infection definitions: EBJIS 2021, ICM 2018, and IDSA 2013.Bone Joint Res2022;11:608-18 PMCID:PMC9533249

[28] Yuan K,Cui ZM.Diagnostic accuracy of C-reactive protein for periprosthetic joint infection: a meta-analysis.Surg Infect2014;15:548-59

[29] Kheir MM,Shohat N,Parvizi J.Routine diagnostic tests for periprosthetic joint infection demonstrate a high false-negative rate and are influenced by the infecting organism.J Bone Joint Surg Am2018;100:2057-65

[30] Glehr M,Hofmann G.Novel biomarkers to detect infection in revision hip and knee arthroplasties.Clin Orthop Relat Res2013;471:2621-8 PMCID:PMC3705066

[31] Patel R,Parvizi J.Advancements in diagnosing periprosthetic joint infections after total hip and knee arthroplasty.Open Orthop J2016;10:654-61 PMCID:PMC5220175

[32] Cats-Baril W,Huff K,Maltenfort M.International consensus on periprosthetic joint infection: description of the consensus process.Clin Orthop Relat Res2013;471:4065-75 PMCID:PMC3825924

[33] Bilgen O,Durak K,Bilgen MS.C-reactive protein values and erythrocyte sedimentation rates after total hip and total knee arthroplasty.J Int Med Res2001;29:7-12

[34] Larsson S,Friberg S.C-reactive protein (CRP) levels after elective orthopedic surgery.Clin Orthop Relat Res1992;275:237-42

[35] Parvizi J,Berbari EF.New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society.Clin Orthop Relat Res2011;469:2992-4 PMCID:PMC3183178

[36] Yáñez-Mó M,Andreu Z.Biological properties of extracellular vesicles and their physiological functions.J Extracell Vesicles2015;4:27066 PMCID:PMC4433489

[37] Fais S,Borras FE.Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine.ACS Nano2016;10:3886-99

[38] Varela L,van Weeren PR.Synovial fluid extracellular vesicles as arthritis biomarkers: the added value of lipid-profiling and integrated omics.Extracell Vesicles Circ Nucl Acids5:276-96 PMCID:PMC11648409

[39] Kolhe R,Sharma A.Sex-specific differences in extracellular vesicle protein cargo in synovial fluid of patients with osteoarthritis.Life2020;10:337 PMCID:PMC7763294

[40] Sallai I,Szatmári A.Activated polymorphonuclear derived extracellular vesicles are potential biomarkers of periprosthetic joint infection.PLoS One2022;17:e0268076 PMCID:PMC9084519

[41] Rüwald JM,Hilgers C.Extracellular vesicle isolation and characterization from periprosthetic joint synovial fluid in revision total joint arthroplasty.J Clin Med2020;9:516 PMCID:PMC7074102

[42] Tan TL,Shohat N.Culture-negative periprosthetic joint infection: an update on what to expect.JB JS Open Access2018;3:e0060 PMCID:PMC6242327

[43] Collins R,Brunak S.Global priorities for large-scale biomarker-based prospective cohorts.Cell Genom2022;2:100141 PMCID:PMC9903754

[44] Logozzi M,Lugini L.High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients.PLoS One2009;4:e5219 PMCID:PMC2667632

[45] Ong J,Rozell JC,Schwarzkopf R.Factors predicting hip joint aspiration yield or “dry taps” in patients with total hip arthroplasty.J Orthop Surg Res2022;17:42 PMCID:PMC8783512

[46] Robbins PD.Regulation of immune responses by extracellular vesicles.Nat Rev Immunol2014;14:195-208 PMCID:PMC4350779

[47] van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles.Nat Rev Mol Cell Biol2018;19:213-28